Upgrade to SI Premium - Free Trial

Damora Therapeutics (DMRA) PT Raised to $60 at Guggenheim

September 25, 2026 6:26 AM
(Updated - September 25, 2026 6:27 AM EDT)

Guggenheim raised its price target on Damora Therapeutics (NASDAQ: DMRA) to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change